Does TAZEMETOSTAT HYDROBROMIDE Cause Product dose omission issue? 183 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 183 reports of Product dose omission issue have been filed in association with TAZEMETOSTAT HYDROBROMIDE (TAZVERIK). This represents 13.8% of all adverse event reports for TAZEMETOSTAT HYDROBROMIDE.
183
Reports of Product dose omission issue with TAZEMETOSTAT HYDROBROMIDE
13.8%
of all TAZEMETOSTAT HYDROBROMIDE reports
4
Deaths
32
Hospitalizations
How Dangerous Is Product dose omission issue From TAZEMETOSTAT HYDROBROMIDE?
Of the 183 reports, 4 (2.2%) resulted in death, 32 (17.5%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAZEMETOSTAT HYDROBROMIDE. However, 183 reports have been filed with the FAERS database.
What Other Side Effects Does TAZEMETOSTAT HYDROBROMIDE Cause?
Off label use (298)
Fatigue (292)
Disease progression (267)
Nausea (207)
Death (106)
Diarrhoea (100)
Decreased appetite (81)
Asthenia (75)
Vomiting (75)
Constipation (66)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which TAZEMETOSTAT HYDROBROMIDE Alternatives Have Lower Product dose omission issue Risk?
TAZEMETOSTAT HYDROBROMIDE vs TAZOBACTAM
TAZEMETOSTAT HYDROBROMIDE vs TBO-FILGRASTIM
TAZEMETOSTAT HYDROBROMIDE vs TEBENTAFUSP-TEBN
TAZEMETOSTAT HYDROBROMIDE vs TECFIDERA
TAZEMETOSTAT HYDROBROMIDE vs TECHNETIUM TC-99M